Source comparison
MK-677 vs Peptide Growth Hormone Secretagogues
Chemical Structure Non-peptide spiropiperidine derivative Short-chain amino acid sequences (4–6 residues) Recombinant 191-amino-acid polypeptide Administration Route Oral (capsule, liquid suspension) Subcutaneous or intramuscular injection Subcutaneous injecti
This comparison does not assign a generated winner or score.
- Chemical Structure
- Non-peptide spiropiperidine derivative
- Short-chain amino acid sequences (4–6 residues)
- Recombinant 191-amino-acid polypeptide
- Administration Route
- Oral (capsule, liquid suspension)
- Subcutaneous or intramuscular injection
- Subcutaneous injection
- Half-Life
- Approximately 24 hours
- 20–120 minutes depending on analogue
- 2–4 hours (requires daily or multiple daily injections)
- Mechanism
- Ghrelin receptor agonist → endogenous GH pulse amplification
- Direct GH replacement → suppresses natural production
- Dosing Frequency
- Once daily
- 1–3 times daily (pre-meal or pre-sleep timing critical)
- Daily or multiple daily
- Effect on Natural GH Production
- Preserves pulsatile secretion patterns
- Suppresses endogenous GH via negative feedback loop
- IGF-1 Elevation Magnitude
- 40–90% above baseline at 25mg daily
- 50–150% above baseline depending on peptide and dose
- 200–400% above baseline (dose-dependent, supraphysiologic levels common)
- Oral Bioavailability
- High (survives gastric acid and first-pass metabolism)
- Zero (peptide bonds degraded in stomach)
- Zero
- Research Assessment
- Sustained amplification without receptor desensitisation over 12+ months documented in clinical trials
- Effective but requires injection compliance; some analogues show tachyphylaxis after 8–12 weeks
- Most potent GH elevation but shuts down natural axis; post-cycle recovery period required
- The practical implication: MK-677 offers the convenience of oral dosing with sustained 24-hour GH elevation, making it the preferred choice for studies requiring daily compliance without injection training. Peptides remain valuable when precise pre-meal or pre-sleep GH pulses are desired, or when researchers want to compare multiple secretagogue analogues. Synthetic rhGH is reserved for replacement therapy studies or protocols explicitly testing supraphysiologic GH exposure.
- Our team has found that researchers often underestimate the compliance advantage of once-daily oral administration. Study dropout rates in protocols requiring twice-daily peptide injections run 30–40% higher than equivalent MK-677 arms over 16-week periods.